Jeffrey Takimoto is the Chief Strategy Officer and Interim Chief Financial Officer at NKMax America. He has over 10 years of experience in both healthcare and finance industries. Jeff was most recently at Bank of America Merrill Lynch, and Credit Suisse in investment banking covering the biotech industry. Prior to investment banking, he was at the Royal Bank of Canada in equity research focused on the biotechnology sector. Prior to his banking career, he worked as a consultant at Booz Allen Hamilton covering the healthcare industry. Dr. Takimoto received his PhD from the University of California, San Diego and the Salk Institute in Biology, and his BS in Molecular, Cell and Development Biology from the University of California, Los Angeles.